Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodora Germetaki

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Future Oncology (London, England)|May 5, 2018
Management and grading of EGFR inhibitor-induced cutaneous toxicityJanette Beech, Theodora Germetaki, Mary Judge, et al.
Journal for Immunotherapy of Cancer|January 12, 2026
Cell therapy in sarcoma: current landscape and future directionsTaha Koray Sahin, Theodora Germetaki, Deniz Can Guven, et al.
JNCI Cancer Spectrum|December 20, 2021
Immunotherapy Efficacy in the Initial Lines of Treatment in Advanced Upper Gastrointestinal Malignancies: A Systematic Review of the LiteratureKonstantinos Kamposioras, Panagiotis Ntellas, Michail Nikolaou, et al.
Acta Oncologica (Stockholm, Sweden)|May 20, 2017
Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinomaGeorge Papaxoinis, Jamie M J Weaver, Leila Khoja, et al.
Acta Oncologica (Stockholm, Sweden)|January 9, 2018
Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapyGeorge Papaxoinis, Konstantinos Kamposioras, Theodora Germetaki, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 24, 2019
The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort StudyGeorge Papaxoinis, Konstantinos Kamposioras, Jamie M J Weaver, et al.
Future Oncology (London, England)|July 28, 2020
Blood-based <i>RAS</i> mutation testing: concordance with tissue-based <i>RAS</i> testing and mutational changes on progressionTheodora Germetaki, Camille Nicholls, Richard A Adams, et al.
Current Oncology (Toronto, Ont.)|December 27, 2024
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SMKonstantinos Kamposioras, Panagiotis Ntellas, Katerina Dadouli, et al.
European Journal of Cancer (Oxford, England : 1990)|November 8, 2022
Tumour infiltrating B cells discriminate checkpoint blockade-induced responsesSara Valpione, Luca G Campana, John Weightman, et al.
Cancers|February 25, 2023
The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM StudyKok Haw Jonathan Lim, Panagiotis Ntellas, Daniel Anderson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Future Oncology (London, England)|May 5, 2018
Management and grading of EGFR inhibitor-induced cutaneous toxicityJanette Beech, Theodora Germetaki, Mary Judge, et al.
Journal for Immunotherapy of Cancer|January 12, 2026
Cell therapy in sarcoma: current landscape and future directionsTaha Koray Sahin, Theodora Germetaki, Deniz Can Guven, et al.
JNCI Cancer Spectrum|December 20, 2021
Immunotherapy Efficacy in the Initial Lines of Treatment in Advanced Upper Gastrointestinal Malignancies: A Systematic Review of the LiteratureKonstantinos Kamposioras, Panagiotis Ntellas, Michail Nikolaou, et al.
Acta Oncologica (Stockholm, Sweden)|May 20, 2017
Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinomaGeorge Papaxoinis, Jamie M J Weaver, Leila Khoja, et al.
Acta Oncologica (Stockholm, Sweden)|January 9, 2018
Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapyGeorge Papaxoinis, Konstantinos Kamposioras, Theodora Germetaki, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 24, 2019
The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort StudyGeorge Papaxoinis, Konstantinos Kamposioras, Jamie M J Weaver, et al.
Future Oncology (London, England)|July 28, 2020
Blood-based <i>RAS</i> mutation testing: concordance with tissue-based <i>RAS</i> testing and mutational changes on progressionTheodora Germetaki, Camille Nicholls, Richard A Adams, et al.
Current Oncology (Toronto, Ont.)|December 27, 2024
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SMKonstantinos Kamposioras, Panagiotis Ntellas, Katerina Dadouli, et al.
European Journal of Cancer (Oxford, England : 1990)|November 8, 2022
Tumour infiltrating B cells discriminate checkpoint blockade-induced responsesSara Valpione, Luca G Campana, John Weightman, et al.
Cancers|February 25, 2023
The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM StudyKok Haw Jonathan Lim, Panagiotis Ntellas, Daniel Anderson, et al.
Pageof 1